Optimize treatment approaches in isocitrate dehydrogenase (IDH) mutant gliomas: open issues

被引：1
|
作者：
Ruda, Roberta [1 ]
机构：
[1] Univ & City Hlth & Sci Hosp, Div Neuro Oncol, Dept Neurosci, Turin, Italy
来源：
NEURO-ONCOLOGY | 2023年 / 25卷 / 01期
关键词：
D O I：
10.1093/neuonc/noac227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
    Cho, Nicholas S.
    Hagiwara, Akifumi
    Eldred, Blaine S. C.
    Raymond, Catalina
    Wang, Chencai
    Sanvito, Francesco
    Lai, Albert
    Nghiemphu, Phioanh
    Salamon, Noriko
    Steelman, Lori
    Hassan, Islam
    Cloughesy, Timothy F.
    Ellingson, Benjamin M.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [2] EPIGENETIC DOWN-REGULATION OF THE METALLOTHIONEIN FAMILY IN ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS
    Ozer, Byram
    Chowdhury, Reshmi
    Li, Tie
    Bui, Yvonne
    Nguyen, Nhung
    Yong, William
    Liau, Linda
    Nghiemphu, Phioanh
    Cloughesy, Timothy
    Lai, Albert
    NEURO-ONCOLOGY, 2017, 19 : 101 - 101
  • [3] Lactate dehydrogenase A silencing in IDH mutant gliomas
    Chesnelong, Charles
    Chaumeil, Myriam M.
    Blough, Michael D.
    Al-Najjar, Mohammad
    Stechishin, Owen D.
    Chan, Jennifer A.
    Pieper, Russell O.
    Ronen, Sabrina M.
    Weiss, Samuel
    Luchman, H. Artee
    Cairncross, J. Gregory
    NEURO-ONCOLOGY, 2014, 16 (05) : 686 - 695
  • [4] Increased Frequency of Presenting with Seizures in Patients with Isocitrate Dehydrogenase 1 (IDH1) Mutant Gliomas
    Chou, Arthur Po-Fei
    Ching, Harry
    Chang, Stephen
    Carrillo, Jose
    Lalezari, Shadi
    Spasic, Marko
    Choy, Winward
    Kim, Andrew
    Selfridge, Julia
    Quan, Jennifer
    Philippou, Yiannis
    Dye, Justin
    Soto, Horacio
    Nagasawa, Daniel
    Mathern, Gary
    Green, Richard
    Yang, Issac
    Prins, Robert
    Lai, Albert
    Liau, Linda
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A440 - A440
  • [5] Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomas
    Friedrich, Mirco
    Bunse, Lukas
    Wick, Wolfgang
    Platten, Michael
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (06) : 368 - 374
  • [6] Develop mutant isocitrate dehydrogenase 1 (IDH1)-expressing gliomas using RCAS/tv-a technology
    Kim, Youngmi
    Lindberg, Nanna
    Bolouri, Hamid
    Delrow, Jeffrey
    Ozawa, Tatsuya
    Holland, Eric
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas
    Sim, Hao-Wen
    Lorrey, Selena
    Khasraw, Mustafa
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2023, 23 (06) : 263 - 276
  • [8] Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas
    Hao-Wen Sim
    Selena Lorrey
    Mustafa Khasraw
    Current Neurology and Neuroscience Reports, 2023, 23 : 263 - 276
  • [9] Analysis of Isocitrate dehydrogenase (IDH) mutation in Gliomas: A call for neurosurgeons and pathologists in Pakistan
    Masood, Muntaha
    Anwar, Rana Fayyaz
    Mehmood, Khalid
    Javed, Maham
    Amjad, Tuaha
    Naseem, Nadia
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2022, 72 (01) : 134 - 140
  • [10] Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
    Miller, Julie J.
    Castro, L. Nicolas Gonzalez
    McBrayer, Samuel
    Weller, Michael
    Cloughesy, Timothy
    Portnow, Jana
    Andronesi, Ovidiu
    Barnholtz-Sloan, Jill S.
    Baumert, Brigitta G.
    Berger, Mitchell S.
    Bi, Wenya Linda
    Bindra, Ranjit
    Cahill, Daniel P.
    Chang, Susan M.
    Costello, Joseph F.
    Horbinski, Craig
    Huang, Raymond Y.
    Jenkins, Robert B.
    Ligon, Keith L.
    Mellinghoff, Ingo K.
    Nabors, L. Burt
    Platten, Michael
    Reardon, David A.
    Shi, Diana D.
    Schiff, David
    Wick, Wolfgang
    Yan, Hai
    von Deimling, Andreas
    van den Bent, Martin
    Kaelin, William G.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2023, 25 (01) : 4 - 25
12345